谷歌浏览器插件
订阅小程序
在清言上使用

Formulation of ‘Ready-to-use’ Human Clinical Doses of 177Lu-Labeled Bisphosphonate Amide of DOTA Using Moderate Specific Activity 177lu and Its Preliminary Evaluation in Human Patient

Radiochimica acta(2020)

引用 0|浏览1
暂无评分
关键词
Bone metastases,palliative treatment,Lu-177,BPAMD,specific activity,skeletal lesions
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要